6. DexCom Inc. (NASDAQ:DXCM)
DexCom, Inc. (NASDAQ: DXCM) takes the No. 6 spot among the 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds, and the company’s story is tied directly to one of the most personal and fast-growing areas of digital health: glucose monitoring. Trading at $70.14, with the stock up 2.17%, DexCom, Inc. (NASDAQ: DXCM) is backed by 70 hedge fund holders and remains one of the most important medical device stocks, diabetes technology stocks, wearable health stocks, glucose monitoring stocks, and digital health stocks in the market. The company is best known for developing continuous glucose monitoring systems, but its latest update shows that DexCom, Inc. (NASDAQ: DXCM) is trying to expand glucose biosensing beyond traditional insulin-using diabetes patients and into broader preventive and personalized care.
On June 23, DexCom, Inc. (NASDAQ: DXCM) announced that the U.S. Food and Drug Administration cleared expanded use of its Stelo Glucose Biosensor for children ages 2 and older who do not use insulin. That is a major development because glucose monitoring has historically been strongly associated with insulin-treated diabetes. By expanding Stelo’s use to younger children who do not use insulin, DexCom, Inc. (NASDAQ: DXCM) is moving deeper into a broader health monitoring market. President and CEO Jake Leach said, “Glucose matters for everyone,” and that statement captures the company’s larger strategy. DexCom, Inc. (NASDAQ: DXCM) is positioning glucose data not only as a diabetes management tool, but also as a health insight tool that can help families and individuals better understand how food, activity, sleep, and stress affect the body.
DexCom, Inc. (NASDAQ: DXCM) also said it plans to broaden access to glucose biosensing while making preventive and customized care more accessible through a redesigned Stelo app. The updated app is expected to begin rolling out in the United States in July for Apple iPhone and Android users, offering easier-to-understand glucose insights connected to food, activity, sleep, and stress. This is where the AI-powered healthcare angle becomes more relevant. Wearable health devices and biosensors are valuable not only because they collect data, but because software can turn that data into understandable insights. As digital health platforms become more advanced, companies like DexCom, Inc. (NASDAQ: DXCM) may be able to help users and healthcare providers make better decisions based on continuous, real-world health information.
The company also has international expansion plans. DexCom, Inc. (NASDAQ: DXCM) said it plans to launch Stelo in the United Kingdom, Australia, New Zealand, and South Korea beginning later this year and continuing into 2027. That gives DexCom, Inc. (NASDAQ: DXCM) a global growth angle, especially as diabetes, prediabetes, obesity, and metabolic health concerns continue to rise around the world. The medical device firm noted that Type 2 diabetes and related health issues are becoming more common in young people, making earlier visibility into blood sugar patterns more important for children and parents. Because Stelo does not require a prescription for this expanded group, it could make glucose data more accessible to families who want to better understand metabolic health without going through traditional prescription channels.
DexCom, Inc. (NASDAQ: DXCM) designs, develops, and markets glucose monitoring systems for ambulatory use by people with diabetes, and its broader biosensing push could give it a stronger position in preventive health and personalized care. For investors searching for AI healthcare stocks, medical device stocks, diabetes technology stocks, wearable health stocks, and digital health stocks to buy, DexCom, Inc. (NASDAQ: DXCM) remains a key name to watch. The company’s future may not be limited to diabetes management alone. If DexCom, Inc. (NASDAQ: DXCM) can successfully expand glucose biosensing into broader consumer health and international markets, it could remain one of the most important players in the next wave of data-driven healthcare.
YOU MUST READ THIS: Top 10 Healthcare Stocks That Could Turn a $1000 Investment Into Something Bigger
Click here to continue reading and checkout the Top 5 AI-Powered Healthcare Stocks That Can Make You Rich.
Disclosure: No relevant interests to disclose. This article was originally published on BioTech HealthX.
